Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026)
Ufp Technologies (UFPT) reported Total Non-Current Liabilities of $234.0 million for Q1 2026, down 15.47% on a YoY basis from $276.9 million in Q1 2025, and up 2.8% quarter-over-quarter from $227.7 million in Q4 2025.
Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies has reported Total Non-Current Liabilities for 16 years, with the latest figure at $234.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities fell 15.47% year-over-year to $234.0 million; the trailing twelve-month figure through Mar 2026 stood at $234.0 million (down 15.47% YoY), and the FY2025 full-year result was $227.7 million, down 17.24% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $234.0 million, up from $227.7 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $304.6 million in Q3 2024, with the low at $104.3 million in Q1 2024.
- Historically, Total Non-Current Liabilities has averaged $185.7 million across 5 years, with a median of $144.7 million in 2022.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 529.29% — and 2024, when it decreased 27.21%.
- Ufp Technologies' Total Non-Current Liabilities stood at $140.2 million in 2022, then retreated by 21.55% to $109.9 million in 2023, then jumped by 150.2% to $275.1 million in 2024, then retreated by 17.24% to $227.7 million in 2025, then rose by 2.8% to $234.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $234.0 million (Q1 2026), $227.7 million (Q4 2025), and $244.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Ufp Technologies | 1.85 Bn | 1.83 Bn | 44.36 Mn | 234.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.05 Mn |
| Dec 31, 2025 | 227.68 Mn |
| Sep 30, 2025 | 244.63 Mn |
| Jun 30, 2025 | 248.92 Mn |
| Mar 31, 2025 | 276.89 Mn |
| Dec 31, 2024 | 275.09 Mn |
| Sep 30, 2024 | 304.61 Mn |
| Jun 30, 2024 | 108.25 Mn |
| Mar 31, 2024 | 104.33 Mn |
| Dec 31, 2023 | 109.95 Mn |
| Sep 30, 2023 | 126.93 Mn |
| Jun 30, 2023 | 137.21 Mn |
| Mar 31, 2023 | 143.33 Mn |
| Dec 31, 2022 | 140.15 Mn |
| Sep 30, 2022 | 142.61 Mn |
| Jun 30, 2022 | 187.79 Mn |
| Mar 31, 2022 | 144.71 Mn |
| Dec 31, 2021 | 124.50 Mn |
| Sep 30, 2021 | 28.86 Mn |
| Jun 30, 2021 | 29.84 Mn |